These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine. Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B Front Immunol; 2018; 9():2371. PubMed ID: 30386336 [TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells. John V; Kotze LA; Ribechini E; Walzl G; Du Plessis N; Lutz MB Front Immunol; 2019; 10():2826. PubMed ID: 31849990 [TBL] [Abstract][Full Text] [Related]
5. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events. Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002 [TBL] [Abstract][Full Text] [Related]
6. SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis. Zhu K; Zhang N; Guo N; Yang J; Wang J; Yang C; Yang C; Zhu L; Xu C; Deng Q; Zhu R; Wang H; Chen X; Shi Y; Li Y; Leng Q Int J Biochem Cell Biol; 2014 Sep; 54():89-97. PubMed ID: 25035167 [TBL] [Abstract][Full Text] [Related]
7. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice. Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908 [TBL] [Abstract][Full Text] [Related]
8. Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines. Hu Z; Jiang W; Gu L; Qiao D; Shu T; Lowrie DB; Lu SH; Fan XY J Mol Med (Berl); 2019 Dec; 97(12):1685-1694. PubMed ID: 31786669 [TBL] [Abstract][Full Text] [Related]
9. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis. Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075 [TBL] [Abstract][Full Text] [Related]
10. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to Namdev P; Patel S; Sparling B; Garg A Front Immunol; 2021; 12():647019. PubMed ID: 33995365 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8 Cartwright ANR; Suo S; Badrinath S; Kumar S; Melms J; Luoma A; Bagati A; Saadatpour A; Izar B; Yuan GC; Wucherpfennig KW Cancer Immunol Res; 2021 Apr; 9(4):470-485. PubMed ID: 33514509 [TBL] [Abstract][Full Text] [Related]
12. Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Singh VK; Khan A; Xu Y; Mai S; Zhang L; Mishra A; Restrepo BI; Pan PY; Chen SH; Jagannath C Front Immunol; 2022; 13():865503. PubMed ID: 35757769 [TBL] [Abstract][Full Text] [Related]
13. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function. du Plessis N; Loebenberg L; Kriel M; von Groote-Bidlingmaier F; Ribechini E; Loxton AG; van Helden PD; Lutz MB; Walzl G Am J Respir Crit Care Med; 2013 Sep; 188(6):724-32. PubMed ID: 23885784 [TBL] [Abstract][Full Text] [Related]
14. The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice. Han C; Wu T; Na N; Zhao Y; Li W; Zhao Y Inflamm Res; 2016 Sep; 65(9):679-88. PubMed ID: 27147271 [TBL] [Abstract][Full Text] [Related]
15. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model. Rubakova E; Petrovskaya S; Pichugin A; Khlebnikov V; McMurray D; Kondratieva E; Baturina I; Kondratieva T; Apt A Tuberculosis (Edinb); 2007 Mar; 87(2):134-44. PubMed ID: 17011827 [TBL] [Abstract][Full Text] [Related]
16. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain. Kim WS; Kim JS; Cha SB; Kim H; Kwon KW; Kim SJ; Han SJ; Choi SY; Cho SN; Park JH; Shin SJ Oncotarget; 2016 May; 7(18):24962-82. PubMed ID: 27097115 [TBL] [Abstract][Full Text] [Related]